Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.
Open Access
- 15 December 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 143 (12) , 3873-3880
- https://doi.org/10.4049/jimmunol.143.12.3873
Abstract
The effects of the cytokine IL-4 on resting and activated human B cells were compared with the effects of known "competence" signals able to drive resting B cells into the cell cycle, including anti-Ig, PMA, anti-CD20, and a recently described competence signal, anti-Bgp95. In proliferation assays, IL-4 was costimulatory with anti-Ig and anti-Bgp95 but not with anti-CD20 or PMA. IL-4 alone triggered increases in expression of class II DR/DQ and CD40, but it did not trigger increases in intracellular free calcium [Ca2+]i in resting B cells or induce resting B cells to leave G0 and enter the G1 phase of the cell cycle. Although IL-4 has some characteristics of competence signals, it was most effective if added to B cells up to 12 h after anti-Ig or anti-Bgp95 rather than before, and thus, in this respect, works more like a progression signal. Like IL-4, all four competence signals for B cells triggered increases in class II and CD40, but only IL-4 consistently induced increases in CD23 surface levels. IL-4 was costimulatory only with anti-Ig and anti-Bgp95, each of which can trigger increases in [Ca2+]i and new protein synthesis of the proto-oncogene c-myc, and can increase attachment of protein kinase C to the plasma membrane. IL-4 was not costimulatory with signals that 1) did not affect [Ca2+]i yet induced c-myc protein synthesis (anti-CD20), 2) only stimulated the translocation of protein kinase C (PMA), or 3) only stimulated increases in [Ca2+]i (calcium ionophore). These results suggest that resting human B cells require at least two intracytoplasmic signals before IL-4 can effectively promote B cell proliferation.This publication has 36 references indexed in Scilit:
- Role of the Bp35 cell surface polypeptide in human B-cell activation.Proceedings of the National Academy of Sciences, 1985
- Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cellsEuropean Journal of Immunology, 1985
- Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.Molecular and Cellular Biology, 1984
- A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: Purification, immunochemical properties and its utility as a general second-antibody reagentJournal of Immunological Methods, 1984
- Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.Proceedings of the National Academy of Sciences, 1984
- Interleukin-induced increase in Ia expression by normal mouse B cells.The Journal of Experimental Medicine, 1984
- TPA (12-O-TETRADECANOYL-PHORBOL-13-ACETATE) ACTIVATION AND DIFFERENTIATION OF HUMAN PERIPHERAL LYMPHOCYTES-B1984
- Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.The Journal of Immunology, 1984
- Crosslinking by ligands to surface immunoglobulin triggers mobilization of intracellular 45Ca2+ in B lymphocytes.The Journal of cell biology, 1979
- Lymphocyte stimulation: a rapid multiparameter analysis.Proceedings of the National Academy of Sciences, 1976